Mizgerd, J. P. Respiratory infection and the impact of pulmonary immunity on lung health and disease.
One promising alternative to antibiotic therapy might be a cell-based immunotherapy approach applying phagocytes to enhance pulmonary immunity.
However, little is known about the impact of Pneumocystis upon the regulation of pulmonary immunity.
Pekovic-Vaughan, V. et al. The circadian clock regulates rhythmic activation of the NRF2/glutathione-mediated antioxidant defense pathway to modulate pulmonary fibrosis.
In the present study, we introduce an immunotherapy approach using iPSC-Mac to enhance innate pulmonary immunity and combat bacterial infections.
Given the pivotal role of phagocytes and especially alveolar macrophages in pulmonary immunity, we introduce a new, cell-based treatment strategy to target bacterial airway infections.
The inflammatory response also alters the pulmonary immunity leading to increased risk for VAP.
We hypothesized that TEA modulates pulmonary endothelial dysfunction in sepsis via an NO-dependent pathway.
Or CARD15, as an immune-response gene, may in some way modulate humoral immunity, predisposing to the generating of ASCA.
Many plant pathogenic fungi secrete effector proteins that facilitate disease development and modulate plant immunity.
